China Universal Asset Management Company’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Buy |
|
|||||
|
2025
Q1 | $133K | Sell |
|
|||||
|
2024
Q4 | $184K | Buy |
|
|||||
|
2024
Q3 | $147K | Buy |
|
|||||
|
2024
Q2 | $102K | Sell |
|
|||||
|
2024
Q1 | $255K | Buy |
|
|||||
|
2023
Q4 | $192K | Buy |
|
|||||
|
2023
Q3 | $34.1K | Buy |
|
|||||
|
2023
Q2 | $24.5K | Sell |
|
|||||
|
2023
Q1 | $29.4K | Buy |
|
|||||
|
2022
Q4 | $29.4K | Buy |
|
|||||
|
2022
Q3 | $26K | Buy |
|